메뉴 건너뛰기




Volumn 24, Issue 24, 2016, Pages 6320-6331

Drug discovery strategies to outer membrane targets in Gram-negative pathogens

Author keywords

Antibacterial; Gram negative; Lipid A; Lipopolysaccharide; Outer membrane

Indexed keywords

ARYLOMYCIN; ARYLOMYCIN D; BACTERIAL PROTEIN; BETA BARREL PROTEIN; CB 102 804; CCT 00431; CCT 00432; COLISTIN; GLOBOMYCIN; JB 95; KRISYNOMYCIN; LIPOPROTEIN; LOLA INHIBITOR; LOLCDE INHIBITOR; LPXA INHIBITOR; LPXC INHIBITOR; MREB INHIBITOR; MUREPAVADIN; MYXOVIRESCIN; NAB 739; NAB 741; POLYMYXIN B; POLYMYXIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; SIGNAL PEPTIDASE I; SIGNAL PEPTIDASE II; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; OUTER MEMBRANE PROTEIN;

EID: 84975125270     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2016.05.004     Document Type: Article
Times cited : (20)

References (93)
  • 43
    • 85027538214 scopus 로고    scopus 로고
    • 42 Sader, H.S., Rhomberg, P.R., Jones, R.N., Antimicrobial Activity of a Novel Polymyxin Analog (CB-182,804) Tested Against Clinical Strain of Gram-negative Bacilli, Including Colistin-resistant Organisms. Presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, Sep 12-15, 2010.
  • 51
    • 85027538529 scopus 로고    scopus 로고
    • 50 Polyphor. March 4, 2013, Polyphor reports successful Phase 1 results for its Pseudomonas selective inhibitor POL7080. [Press release], Retrieved from http://www.nabativi.org/upload/file/Polyphor%20POL7080_Press%20Release_.pdf.
  • 52
    • 85027538361 scopus 로고    scopus 로고
    • 51 Urder, M., Bogdanovic, J., Lo Monte, F., Moehle, K., Zerbe, K., Omasits, U., Ahrens, C.H., Pessi, G., Eberl, L., Robinson, J.A., J. Biol. Chem., 2015 paper in press, http://www.jbc.org/cgi/doi/10.1074/jbc.M115.69172.
  • 60
    • 85027538824 scopus 로고    scopus 로고
    • 59 Serio, A.W., Kubo, A., Lopez, S., Gomez, M., Corey, V.C., Andrews, L., Schwartz, M.A., Kasar, R., McEnroe, G., Aggen, J., Miller, G., Armstrong, E.S., Structure, Potency and Bactericidal Activity of ACHN-975, a First-in-class LpxC Inhibitor. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy, F-1227, Denver CO, 2013.
  • 61
    • 85027539217 scopus 로고    scopus 로고
    • 60 ACHN-975 completed December 2012. Clinicaltrials.gov, NCT01597947. SEC form S-1 registration statement on ACHN-975, January 24, 2014. http://www.sec.gov/Archives/edgar/data/1301501/000119312514020548/d623715ds1.htm.
  • 70
    • 84953299648 scopus 로고    scopus 로고
    • 69 Mao, G., Zhao, Y., Kang, X., Li, Z., Zhang, Y., Wang, X., Sun, F., Sankaran, K., Zhang, X.C., Nat. Commun., 2016, 10.1038/ncomms10198.
  • 87
    • 85027538407 scopus 로고    scopus 로고
    • 86 Brown, D.G., Granger, B., Lister, T., McLeod, S., Kutschke, A., Ferguson, K., Nayar, A., Knight, S., Litten, B., Blackett, C., Plant, H., Structure Activity Relationships (SAR) of 4-(3-(3-Alkoxyphenyl)-1H-pyrazol-4-yl)pyridines as Novel Antibacterial Leads Acting via the LolCDE Complex. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Sep. 5–9, Washington DC, 2014.
  • 93
    • 84951845275 scopus 로고    scopus 로고
    • 92 Maxson, T., Mitchell, D.A., Tetrahedron, 2015, 10.1016/j.tet.2015.09.069.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.